Chih Wen Li
Founder bei SYNCORE BIOTECHNOLOGY CO.,LTD
Profil
Chih Wen Li has founded SynCore Biotechnology Co., Ltd.
in 2008 where he holds the title of Chairman.
Currently, he holds the position of Chairman at Sinphar Pharmaceutical Co. Ltd., Universal Next Technologies, Inc., Sunetic Biotech, Inc., ZuniMed Biotech Co., Ltd., and Director at Ching Ta Investment Co. Ltd.
He is also a member of the Society of Chinese Bioscientists in America.
Mr. Li received his undergraduate degree from Kaohsiung Medical University.
Aktive Positionen von Chih Wen Li
| Unternehmen | Position | Beginn |
|---|---|---|
| SINPHAR PHARMACEUTICAL CO.,LTD. | Chairman | 10.02.2011 |
| SYNCORE BIOTECHNOLOGY CO.,LTD | Founder | 26.06.2008 |
| Ching Ta Investment Co. Ltd. /Sinphar/ | Director/Board Member | - |
| Sunetic Biotech, Inc. | Chairman | - |
| Society of Chinese Bioscientists in America | Corporate Officer/Principal | - |
| ZuniMed Biotech Co., Ltd. | Chairman | - |
Universal Next Technologies, Inc.
 Universal Next Technologies, Inc. Financial ConglomeratesFinance Part of Sinphar Pharmaceutical Co. Ltd., Universal Next Technologies, Inc. provides investment services. | Chairman | - |
Ausbildung von Chih Wen Li
| Kaohsiung Medical University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SINPHAR PHARMACEUTICAL CO.,LTD. | Health Technology |
| SYNCORE BIOTECHNOLOGY CO.,LTD | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Universal Next Technologies, Inc.
Universal Next Technologies, Inc. Financial ConglomeratesFinance Part of Sinphar Pharmaceutical Co. Ltd., Universal Next Technologies, Inc. provides investment services. | Finance |
| Ching Ta Investment Co. Ltd. /Sinphar/ | |
| Society of Chinese Bioscientists in America | |
| Sunetic Biotech, Inc. | |
| ZuniMed Biotech Co., Ltd. |
